Skip to Main Content

Paper Details

Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors.
Nat Genet
266
2016
ERCC2, ERCC2 mutations, NER gene, core NER gene, nucleotide, tumor, tumors, urothelial cancer, urothelial tumor, urothelial tumors
Author NameAffiliation
Jaegil KimBroad Institute of MIT and Harvard
Paz PolakBroad Institute of MIT and Harvard
Paz PolakCancer Center, Massachusetts General Hospital
Paz PolakMassachusetts General Hospital
Paz PolakHarvard Medical School
Paz PolakBroad Institute of MIT and Harvard
Paz PolakHarvard Medical School
Paz PolakMassachusetts General Hospital
Paz PolakCancer Center, Massachusetts General Hospital
Atanas KamburovBroad Institute of MIT and Harvard
Atanas KamburovHarvard Medical School
Atanas KamburovMassachusetts General Hospital
Atanas KamburovCancer Center, Massachusetts General Hospital
Eliezer M Van AllenBroad Institute of MIT and Harvard
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenHarvard Medical School
Eliezer M Van AllenBroad Institute of MIT and Harvard
Eliezer M Van AllenHarvard Medical School
Eliezer M Van AllenDana-Farber Cancer Institute
Alan D D'AndreaBrigham & Women's Hospital, Dana-Farber Cancer Institute
Alan D D'AndreaCenter for DNA Damage and Repair, Dana-Farber Cancer Institute
Alan D D'AndreaHarvard Medical School
Alan D D'AndreaBrigham & Women's Hospital, Dana-Farber Cancer Institute
Alan D D'AndreaHarvard Medical School
Alan D D'AndreaCenter for DNA Damage and Repair, Dana-Farber Cancer Institute
Gad GetzBroad Institute of MIT and Harvard
Gad GetzHarvard Medical School
Gad GetzMassachusetts General Hospital
Gad GetzCancer Center, Massachusetts General Hospital
Gad GetzBroad Institute of MIT and Harvard
Gad GetzHarvard Medical School
Gad GetzMassachusetts General Hospital
Gad GetzCancer Center, Massachusetts General Hospital
  • 1 - 33

Datasets

Release 1.2